BCD-089

BIOLOGICAL2 trials

Sponsors

Biocad

Conditions

HealthyRheumatoid Arthritis

Phase 1

First-in-human Study of Safety, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-089 in Healthy Subjects

CompletedNCT03103438

Start: 2016-11-30End: 2017-05-31Updated: 2021-02-26

Phase 3

Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

CompletedNCT04227366

BiocadRheumatoid Arthritis

Start: 2019-11-19End: 2022-03-01Updated: 2022-05-12